Trial Profile
Effect of Levosimedan or Placebo on Exercise Capatity and hemodynamics in Patients with Advanced Chronic Heart Failure (LOCO-CHF trial)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2023
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms LOCO-CHF trial
- 13 Oct 2023 Status changed from recruiting to completed.
- 13 Oct 2023 This trial has been completed in Denmark, according to European Clinical Trials Database record.
- 15 Jul 2019 Status changed from not yet recruiting to recruiting.